![Richard van Etten](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard van Etten
Direttore/Membro del Consiglio presso Helio Genomics, Inc.
Posizioni attive di Richard van Etten
Società | Posizione | Inizio | Fine |
---|---|---|---|
Helio Genomics, Inc.
![]() Helio Genomics, Inc. Information Technology ServicesTechnology Services Helio Genomics, Inc. is a leading healthcare company based in Irvine, CA, that focuses on early cancer detection through cutting-edge research and development. The private company's mission is to simplify cancer screening and enhance patient outcomes across diverse populations. Helio Genomics has pioneered breakthrough innovations in genomics, providing a strong foundation for its sister company, Lamh. Helio Genomics is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw. The company's development program is focused on liver, colon, breast, and lung cancer. The company has R&D, GMP, and CLIA facilities in Irvine, CA, and West Lafayette, IN. The CEO of the company is Justin Chen Li. | Direttore/Membro del Consiglio | - | - |
Corporate Officer/Principal | - | - |
Storia della carriera di Richard van Etten
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Settori
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Helio Genomics, Inc.
![]() Helio Genomics, Inc. Information Technology ServicesTechnology Services Helio Genomics, Inc. is a leading healthcare company based in Irvine, CA, that focuses on early cancer detection through cutting-edge research and development. The private company's mission is to simplify cancer screening and enhance patient outcomes across diverse populations. Helio Genomics has pioneered breakthrough innovations in genomics, providing a strong foundation for its sister company, Lamh. Helio Genomics is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw. The company's development program is focused on liver, colon, breast, and lung cancer. The company has R&D, GMP, and CLIA facilities in Irvine, CA, and West Lafayette, IN. The CEO of the company is Justin Chen Li. | Technology Services |
- Borsa valori
- Insiders
- Richard van Etten
- Esperienza